ArticleDiabetology & metabolic syndrome2016

Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial.

Yaeko Kondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.